» Articles » PMID: 1453588

Predicting Chronic Renal Insufficiency in Idiopathic Membranous Glomerulonephritis

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 1992 Oct 1
PMID 1453588
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

We developed an approach in quantifying the risk of developing chronic renal insufficiency (CRI) based on a cohort of 184 patients with idiopathic membranous glomerulonephritis (IMGN), prospectively followed by the Toronto Glomerulonephritis Registry between 1974 and 1988. After a mean follow-up period of 5.8 years, 26% of patients developed CRI (defined as persistent reduction of creatinine clearance (CCr) less than or equal to 60 ml/min/1.73 m2 for greater than or equal to 12 months). We found that when compared to the baseline probability of the unselected patients, the severity of proteinuria at kidney biopsy added only marginally to the prediction of CRI. We introduced a special test condition: persistent proteinuria (PP) (that is, duration of proteinuria, g/day, above different cut-off levels). We examined the positive predictive value (PPV) and sensitivity (SEN) of 15 arbitrarily chosen levels of PP (that is, proteinuria greater than or equal to 4, 6 or 8 g/day persisting for greater than or equal to 6, 9, 12, 18 or 24 months) to select levels with optimal predictive characteristics. We found that PP greater than or equal to 8 g/day for greater than or equal to six months was a simple and useful predictor of CRI with a PPV and SEN of 66%. To further improve our prediction, we tested the following parameters: age, sex, initial SCr and CCr, proteinuria, serum albumin, hypertension, rate of change of CCr over time, and therapy (steroids +/- immunosuppressive drugs) in a multivariate analysis. Proteinuria, initial CCr, and rate of change of CCr were most important in predicting CRI.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

The Association of Lower Levels of Baseline Proteinuria With Earlier Remission in Primary Membranous Nephropathy.

Joseph J, Subramanian T, Vellaisamy M, Nd S, Surendran S, Kaliaperumal T Cureus. 2024; 16(6):e61918.

PMID: 38978879 PMC: 11230608. DOI: 10.7759/cureus.61918.


Membranous nephropathy: pathogenesis and treatments.

Wang M, Yang J, Fang X, Lin W, Yang Y MedComm (2020). 2024; 5(7):e614.

PMID: 38948114 PMC: 11214595. DOI: 10.1002/mco2.614.


Ten tips on immunosuppression in primary membranous nephropathy.

Trujillo H, Caravaca-Fontan F, Praga M Clin Kidney J. 2024; 17(6):sfae129.

PMID: 38915435 PMC: 11195618. DOI: 10.1093/ckj/sfae129.


Outcomes of primary membranous nephropathy refractory to immunosuppressants.

Nayak S, Chauhan P, Jha V, Ramachandran R, Bose B Clin Kidney J. 2024; 17(5):sfae113.

PMID: 38726209 PMC: 11079664. DOI: 10.1093/ckj/sfae113.


Fractional excretion of total protein predicts renal prognosis in Japanese patients with primary membranous nephropathy.

Kuno H, Kanzaki G, Sasaki T, Okabayashi Y, Haruhara K, Yokote S Clin Kidney J. 2024; 17(5):sfae071.

PMID: 38699483 PMC: 11063954. DOI: 10.1093/ckj/sfae071.